Circulating platelet‐derived extracellular vesicles are decreased after remote ischemic preconditioning in patients with coronary disease: A randomized controlled trial-Reference-Cited by-同舟云学术

Circulating platelet‐derived extracellular vesicles are decreased after remote ischemic preconditioning in patients with coronary disease: A randomized controlled trial

Published:2021-08-10 Issue:10 Volume:19 Page:2605-2611
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Reddel Caroline J.¹,Pennings Gabrielle J.¹,Lau Jerrett K.¹²,Chen Vivien M.¹³,Kritharides Leonard¹²

Affiliation:

1. ANZAC Research InstituteConcord Repatriation General HospitalUniversity of Sydney Concord NSW Australia

2. Department of Cardiology Concord Repatriation General Hospital Concord NSW Australia

3. Department of Hematology Concord Repatriation General HospitalUniversity of Sydney Concord NSW Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15441

Reference29 articles.

1. Cardiac Remote Ischaemic Preconditioning: Mechanistic and Clinical Considerations

2. Safety and Efficacy of Remote Ischemic Preconditioning in Patients With Severe Carotid Artery Stenosis Before Carotid Artery Stenting

3. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

4. The Nature and Significance of Platelet Products in Human Plasma

5. Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia/reperfusion injury by transferring miR-24

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered extracellular vesicles as therapeutics of degenerative orthopedic diseases;Frontiers in Bioengineering and Biotechnology;2023-06-09

2. Effects of remote ischaemic preconditioning on myocardial injury after major abdominal surgery in patients at high risk for cardiovascular adverse events in China (RIPC-MAS): protocol for a randomised, sham-controlled, observer-blinded trial;BMJ Open;2023-06

3. Identification of a Distinct Platelet Phenotype in the Elderly: ADP Hypersensitivity Coexists With Platelet PAR (Protease-Activated Receptor)-1 and PAR-4–Mediated Thrombin Resistance;Arteriosclerosis, Thrombosis, and Vascular Biology;2022-08